Antibody data
- Antibody Data
- Antigen structure
- References [0]
- Comments [0]
- Validations
- Western blot [1]
- Immunocytochemistry [1]
- Immunohistochemistry [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- TA504035 - Provider product page
- Provider
- OriGene
- Proper citation
- OriGene Cat#TA504035, RRID:AB_11124359
- Product name
- NUCB1 (Nucleobindin 1) mouse monoclonal antibody, clone OTI1G3 (formerly 1G3)
- Antibody type
- Monoclonal
- Description
- NUCB1 (Nucleobindin 1) mouse monoclonal antibody, clone OTI1G3 (formerly 1G3)
- Host
- Mouse
- Conjugate
- Unconjugated
- Epitope
- NUCB1
- Isotype
- IgG
- Antibody clone number
- OTI1G3
- Vial size
- 100 µl
- Concentration
- 0.7 mg/ml
No comments: Submit comment
Supportive validation
- Submitted by
- OriGene (provider)
- Main image
- Experimental details
- HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY NUCB1 (RC201786, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-NUCB1.
- Validation comment
- WB
Supportive validation
- Submitted by
- OriGene (provider)
- Main image
- Experimental details
- Anti-NUCB1 mouse monoclonal antibody (TA504035) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY NUCB1(RC201786).
- Validation comment
- IF
Supportive validation
- Submitted by
- OriGene (provider)
- Main image
- Experimental details
- Immunohistochemical staining of paraffin-embedded Carcinoma of Human kidney tissue using anti-NUCB1 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA504035)
- Validation comment
- IHC
- Submitted by
- OriGene (provider)
- Main image
- Experimental details
- Immunohistochemical staining of paraffin-embedded Human liver tissue within the normal limits using anti-NUCB1 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA504035)
- Validation comment
- IHC